Literature DB >> 27699550

Continuation of direct oral anticoagulants in the acute phase of ischemic stroke. A case series.

Manuel Cappellari1, Paolo Bovi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27699550     DOI： 10.1007/s11239-016-1430-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  8 in total

1.  Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.

Authors:  Manuel Cappellari; Monica Carletti; Alessandra Danese; Paolo Bovi
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

2.  Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.

Authors:  Fan Z Caprio; Richard A Bernstein; Mark J Alberts; Yvonne Curran; Deborah Bergman; Alexander W Korutz; Faiz Syed; Sameer A Ansari; Shyam Prabhakaran
Journal:  Cerebrovasc Dis       Date:  2014-11-13       Impact factor: 2.762

3.  Early initiation of new oral anticoagulants in acute stroke and TIA patients with nonvalvular atrial fibrillation.

Authors:  Kensaku Shibazaki; Kazumi Kimura; Junya Aoki; Naoki Saji; Kenichiro Sakai
Journal:  J Neurol Sci       Date:  2013-06-03       Impact factor: 3.181

4.  Early administration of non-vitamin K antagonist oral anticoagulants for acute ischemic stroke patients with atrial fibrillation in comparison with warfarin mostly combined with heparin.

Authors:  Eiichi Nomura; Tomohiko Ohshita; Eiji Imamura; Shinichi Wakabayashi; Hiroshi Kajikawa; Naohisa Hosomi; Masayasu Matsumoto
Journal:  Circ J       Date:  2015-01-23       Impact factor: 2.993

5.  Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Hans-Christoph Diener; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2015-08-31       Impact factor: 5.214

6.  Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.

Authors:  A H Abdul-Rahim; R L Fulton; B Frank; T Tatlisumak; M Paciaroni; V Caso; H-C Diener; K R Lees
Journal:  Eur J Neurol       Date:  2014-10-16       Impact factor: 6.089

7.  Helsinki experience on nonvitamin K oral anticoagulants for treating cervical artery dissection.

Authors:  Satu Mustanoja; Tiina M Metso; Jukka Putaala; Noora Heikkinen; Elena Haapaniemi; Oili Salonen; Turgut Tatlisumak
Journal:  Brain Behav       Date:  2015-05-30       Impact factor: 2.708

8.  New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons.

Authors:  Partha Sardar; Saurav Chatterjee; Wen-Chih Wu; Edgar Lichstein; Joydeep Ghosh; Shamik Aikat; Debabrata Mukherjee
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240
  8 in total
  1 in total

1.  Clinical presentation, diagnostic findings and management of cerebral ischemic events in patients on treatment with non-vitamin K antagonist oral anticoagulants - A systematic review.

Authors:  Thomas Raphael Meinel; Sebastién Frey; Marcel Arnold; Sarah Kendroud; Urs Fischer; Johannes Kaesmacher; Mirjam Rachel Heldner; Simon Jung
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.